Miltenyi Biotec

miltenyibiotec.com · Bergisch Gladbach, Germany

Miltenyi Biotec is a global biotechnology company that develops and manufactures products and services for cell separation, cell therapy, flow cytometry, and related research and clinical applications. It serves academic and industrial researchers, biopharmaceutical companies, and clinical institutions with instruments, reagents, and contract services that support basic research, drug development, and cell and gene therapy manufacturing. Revenue is generated primarily through the sale of lab equipment and consumables, as well as specialized services and solutions for cell processing and analysis.

Revenue
$250M - $1B
Employees
1,001 - 5,000
Founded
1989
Headquarters
Bergisch Gladbach, Germany

Miltenyi Biotec customers on Arbolus

Total customers 13 12 current · 1 former
Reviews growth 9 new reviews since Jun 2026

Customers who reviewed Miltenyi Biotec

Seniority of Miltenyi Biotec customers

The largest group of people who reviewed Miltenyi Biotec holds Director roles (50%), followed by Manager (25%) and C-Suite (25%).

  • Director 50%
  • Manager 25%
  • C-Suite 25%

Customers sample

Other Analyst Not specified NPS 10
Not specified Director NPS 10
Engineering Leader Director NPS 9

Employer names and spend open in the full report, along with the other 10 customers.

What 13 Arbolus experts think of Miltenyi Biotec

Overall sentiment: Positive

NPS distribution shows 61.5% Promoters, 23.1% Passives, and 15.4% Detractors, with an NPS score of 46.2 and an average NPS of 8.23. Renewal intent is strong, with 75% of respondents indicating they would renew. Stickiness is high, as 76.9% of users have been with the platform for more than one year. Key expert feedback highlights automation, reliability, and regulatory compliance as strengths, while vendor lock-in and supply chain risks are noted as weaknesses.

Everything 13 customers told us about Miltenyi Biotec.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

46 Net Promoter Score, from 13 scored reviews
  • Promoters 8
  • Passives 3
  • Detractors 2

Praised

  • AI-Driven Process Optimization
  • Automation and Closed-System Reliability

Criticised

  • Proprietary Ecosystem and Supply Chain Risk
  • Competitive Threat from Open Systems

What Miltenyi Biotec customers say

Automation and Closed-System Reliability

“I would recommend Miltenyi because their system allows you to take a complex cell therapy out of a massive cleanroom and into a highly controlled, automated, factory-in-a-box.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

AI-Driven Process Optimization

“If an enterprise AI model could dynamically monitor cell metabolic data and autonomously adjust operating parameters, we could drastically improve batch yields without manual process engineering.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Proprietary Ecosystem and Supply Chain Risk

“The primary gap with Miltenyi is their strict walled garden ecosystem, which creates extreme supply chain vulnerability if there is a backorder on a specific consumable.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Renewal intent

Plan to renew 80%
  • Will renew 4
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 1 answer
  • Director 100% 2 answers
  • Manager 50% 2 answers
  • 8.8/10 Average score from customers who will renew
  • 6/10 Average score from undecided customers

Report

Nov 2026 13 + 1

For people who use Miltenyi Biotec

Do you use Miltenyi Biotec at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of Miltenyi Biotec have already contributed

Takes a few minutes. Your identity stays anonymous.